Since expression of aromatase is increased in astrocytes following cerebral ischemia it seems likely that this astrocyte-specific elevation of E2 plays a major role in the neuroprotective effects observed in the global aromatase knockout mice and aromatase inhibitor/knockdown studies discussed above. The gene discussed is CYP19A1; the disease is Cerebral ischemia.